EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of the detection limits of PCR for identification of Mycoplasma pneumoniae in clinical samples


Molecular and Cellular Probes 8(2): 125-130
Evaluation of the detection limits of PCR for identification of Mycoplasma pneumoniae in clinical samples
The detection limits of the polymerase chain reaction (PCR) for Mycoplasma pneumoniae were determined using specimens from persons known to have had M. pneumoniae pneumonia. Four primers were selected from the known sequence of the P1 gene. The primer pair (P1-178 and P1-809) which generates a 631 fragment gave the lowest detection limit. Nineteen of 21 throat swabs, which contained between 0.06 and 2 colony-forming units (CFU) per microlitre, from culture positive patients, were positive by PCR. The fact that M. pneumoniae grows in broth culture in spherules causes problems for determining the number of CFU detected in PCR. Filtering broth cultures through a 0.6 micron polycarbonate filter increased the number of CFUs two-to-ten-fold compared to unfiltered cultures. The lysis method needed to assay throat swabs differed from that necessary for broth cultures in that proteinase K treatment for 18 h increased the detection limit 10- to 100-fold when compared to NaOH digestion.

(PDF same-day service: $19.90)

Accession: 046014943

PMID: 7935510

DOI: 10.1006/mcpr.1994.1017



Related references

Single tube real time PCR for detection of Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydophila pneumoniae and Legionella pneumophila from clinical samples of CAP. Acta Microbiologica et Immunologica Hungarica 59(2): 171-184, 2012

Development and evaluation of Chlamylege, a new commercial test allowing simultaneous detection and identification of Legionella, Chlamydophila pneumoniae, and Mycoplasma pneumoniae in clinical respiratory specimens by multiplex PCR. Journal of Clinical Microbiology 43(7): 3247-3254, 2005

Evaluation of diagnosis of atypical pneumonia by multiplex PCR-based assay Simultaneous detection of Legionella -pneumophila, Chlamydia pneumoniae, and Mycoplasma pneumoniae in clinical samples from patients with pneumonia. Abstracts of the General Meeting of the American Society for Microbiology 102: 144, 2002

Detection of Mycoplasma pneumoniae and Mycoplasma genitalium in clinical samples by polymerase chain reaction. Clinical Infectious Diseases 17 Suppl 1: S83-S89, 1993

PCR method for detection of Mycoplasma pneumoniae and Mycoplasma fermentans in clinical samples Use of internal control DNAs to detect false-negatives. Abstracts of the General Meeting of the American Society for Microbiology 94(0): 172, 1994

Development of a multiplex real-time PCR assay for detection of Mycoplasma pneumoniae, Chlamydia pneumoniae and mutations associated with macrolide resistance in Mycoplasma pneumoniae from respiratory clinical specimens. Springerplus 4: 684-684, 2015

Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR. Journal of Microbiological Methods 41(1): 45-51, June, 2000

Rapid detection of Mycoplasma pneumoniae in clinical samples by the polymerase chain reaction. Journal of Medical Microbiology 38(3): 166-170, 1993

Evaluation of a new commercial kit for the detection of Chlamydophila pneumoniae, Mycoplasma pneumoniae and Legionella species in respiratory specimens through a prospective pediatric clinical study. Abstracts of the General Meeting of the American Society for 105): 121, 2005

Evaluation of ELISA kits for detection of Mycoplasma pneumoniae--specific IgG, IgA, IgM antibodies on the diagnosis of Mycoplasma pneumoniae infection in children. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 79(7): 457-463, 2005